# Delaying the Onset of Nearsightedness Until Treatment Study

> **NCT06029530** · PHASE1 · WITHDRAWN · sponsor: **Ohio State University**

## Conditions studied

- Myopia

## Interventions

- **DRUG:** Atropine Ophthalmic

## Key facts

- **NCT ID:** NCT06029530
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-01-01
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** sIRB determined feasibility study could not be done because of no benefits of the treatment drops in short time violated FDA requirements
- **Last updated:** 2024-04-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06029530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06029530, "Delaying the Onset of Nearsightedness Until Treatment Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06029530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*